People living with human immunodeficiency virus (HIV) are living longer since the advent of
effective combined antiretroviral therapy (cART). While cART substantially decreases the
risk of developing some cancers, HIV-infected individuals remain at high risk for Kaposi
sarcoma, lymphoma, and several solid tumors. Currently HIV-infected patients represent an
aging group, and malignancies have become a leading cause of morbidity and mortality.
Tailored cancer-prevention strategies are needed for this population. In this review we …